Reframing the association and significance of co-morbidities in heart failure

被引:190
作者
Triposkiadis, Filippos [1 ]
Giamouzis, Gregory [1 ]
Parissis, John [2 ]
Starling, Randall C. [3 ,4 ]
Boudoulas, Harisios [5 ,6 ,7 ]
Skoularigis, John [1 ]
Butler, Javed [8 ]
Filippatos, Gerasimos [2 ]
机构
[1] Larissa Univ Hosp, Dept Cardiol, POB 1425, Larisa 41110, Greece
[2] Athens Univ, Dept Cardiol, Hosp Attikon, Athens, Greece
[3] Cleveland Clin, Kaufman Ctr Heart Failure, Cleveland, OH 44106 USA
[4] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
[5] Ohio State Univ, Columbus, OH 43210 USA
[6] Acad Athens, Biomed Res Fdn, Athens, Greece
[7] Aristotelian Univ Thessaloniki, Thessaloniki, Greece
[8] SUNY Stony Brook, Sch Med, Cardiol Div, Stony Brook, NY 11794 USA
关键词
Heart failure; Hypertension; Coronary artery disease; Myocardial infarction; Atrial fibrillation; Obstructive pulmonary disease; Anaemia; Diabetes; Kidney disease; Renal failure; Sleep-disordered breathing; Obesity; Depression; OBSTRUCTIVE PULMONARY-DISEASE; REDUCED EJECTION FRACTION; WORSENING RENAL-FUNCTION; CORONARY-ARTERY-DISEASE; CENTRAL SLEEP-APNEA; VENTRICULAR SYSTOLIC DYSFUNCTION; CONVERTING-ENZYME INHIBITORS; 2013 ACCF/AHA GUIDELINE; AIR-FLOW OBSTRUCTION; ATRIAL-FIBRILLATION;
D O I
10.1002/ejhf.600
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several co-existing diseases and/or conditions (co-morbidities) are present in patients with heart failure (HF), with diverse clinical relevance. Multiple mechanisms may underlie the co-existence of HF and co-morbidities, including direct causation, associated risk factors, heterogeneity, and independence. The complex inter-relationship of co-morbidities and their impact on the cardiovascular system contribute to the features of HF, both with reduced (HFrEF) and preserved ejection fraction (HFpEF). The purpose of this work is to provide an overview of the contribution of major cardiac and non-cardiac co-morbidities to HF development and outcomes, in the context of both HFpEF and HFrEF. Accordingly, epidemiological evidence linking co-morbidities to HF and the effect of prevalent and incident co-morbidities on HF outcome will be reviewed.
引用
收藏
页码:744 / 758
页数:15
相关论文
共 144 条
[1]   Airflow obstruction, lung function, and risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study [J].
Agarwal, Sunil K. ;
Heiss, Gerardo ;
Barr, R. Graham ;
Chang, Patricia P. ;
Loehr, Laura R. ;
Chambless, Lloyd E. ;
Shahar, Eyal ;
Kitzman, Dalane W. ;
Rosamond, Wayne D. .
EUROPEAN JOURNAL OF HEART FAILURE, 2012, 14 (04) :414-422
[2]   Effects of digoxin on morbidity and mortality in diastolic heart failure: The ancillary Digitalis Investigation Group trial [J].
Ahmed, Ali ;
Rich, Michael W. ;
Fleg, Jerome L. ;
Zile, Michael R. ;
Young, James B. ;
Kitzman, Dalane W. ;
Love, Thomas E. ;
Aronow, Wilbert S. ;
Adams, Kirkwood F., Jr. ;
Gheorghiade, Mihai .
CIRCULATION, 2006, 114 (05) :397-403
[3]   Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management [J].
Alpert, Martin A. ;
Lavie, Carl J. ;
Agrawal, Harsh ;
Aggarwal, Kul B. ;
Kumar, Senthil A. .
TRANSLATIONAL RESEARCH, 2014, 164 (04) :345-356
[4]   Anemia and its relationship to clinical outcome in heart failure [J].
Anand, I ;
McMurray, JJV ;
Whitmore, J ;
Warren, M ;
Pham, A ;
McCamish, MA ;
Burton, PBJ .
CIRCULATION, 2004, 110 (02) :149-154
[5]   Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure results - From Val-HeFT [J].
Anand, IS ;
Kuskowski, MA ;
Rector, TS ;
Florea, VG ;
Glazer, RD ;
Hester, A ;
Chiang, YT ;
Aknay, N ;
Maggioni, AP ;
Opasich, C ;
Latini, R ;
Cohn, JN .
CIRCULATION, 2005, 112 (08) :1121-1127
[6]   Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: a nationwide cohort study [J].
Andersson, Charlotte ;
Norgaard, Mette L. ;
Hansen, Peter R. ;
Fosbol, Emil L. ;
Schmiegelow, Michelle ;
Weeke, Peter ;
Olesen, Jonas B. ;
Raunso, Jakob ;
Jorgensen, Casper H. ;
Vaag, Allan ;
Kober, Lars ;
Torp-Pedersen, Christian ;
Gislason, Gunnar H. .
EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (12) :1333-1338
[7]   Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. [J].
Anker, Stefan D. ;
Comin Colet, Josep ;
Filippatos, Gerasimos ;
Willenheimer, Ronnie ;
Dickstein, Kenneth ;
Drexler, Helmut ;
Luescher, Thomas F. ;
Bart, Boris ;
Banasiak, Waldemar ;
Niegowska, Joanna ;
Kirwan, Bridget-Anne ;
Mori, Claudio ;
Rothe, Barbara von Eisenhart ;
Pocock, Stuart J. ;
Poole-Wilson, Philip A. ;
Ponikowski, Piotr .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25) :2436-2448
[8]  
[Anonymous], 2015, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD010139
[9]  
[Anonymous], 2015, Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease
[10]   Atrial Fibrillation and Heart Failure Treatment Considerations for a Dual Epidemic [J].
Anter, Elad ;
Jessup, Mariell ;
Callans, David J. .
CIRCULATION, 2009, 119 (18) :2516-2525